Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Wyld Issues Convertible Loan Notes

7 May 2020 07:00

Tern PLC (TERN) Wyld Issues Convertible Loan Notes 07-May-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

7 May 2020

Tern Plc ("Tern" or the "Company")

Wyld Networks Limited issues of £400,000 of Convertible Loan Notes to third party

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that its portfolio company, Wyld Networks Limited ("Wyld"), has secured £400,000 from an investor to fund its growing pipeline of opportunities and for general working capital purposes, by way of an unsecured Convertible Loan Note facility ("CLN"). The CLN has been issued in full. The CLN also includes an option to convert into Tern shares under certain circumstances.

 

Tern's CEO, Al Sisto, said:

"Wyld has gone from strength to strength over the past 12 months and this external investment is a huge vote of confidence in Wyld's management team, which has transformed this start up business and its pipeline in a very short space of time. This external investment is from an investor who is seeking exposure to the mid- to long-term growth opportunities presented by IoT innovation and to have received its additional support early in the development of Wyld is very validating. With contracts signed to provide IoT solutions, a cooperation agreement with one of the world's largest satellite operators secured and its technology now patent pending, Wyld has reached an important point in its development. These funds will enable Wyld to continue on this upward trajectory towards the goal of securing a syndicated Series A funding round in due course."

 

The CLN, which bears interest at 5% per annum, is convertible into Wyld shares, at the option of the investor ("CLN Holder"), at either 25%, 50%, 75% or 100% of the principal of the CLN, on completion of an exit or Wyld equity fundraise of at least £1 million from a third party (in both cases) other than Tern before 6 May 2021 (the "Maturity Date"). This conversion would take place at a 20% discount to the Wyld equity fundraise price or the exit price per Wyld share.

 

Following a conversion event, any amount of the CLN not converted into Wyld shares will automatically be converted into fully paid ordinary shares of 0.02 p each in the capital of Tern ("Tern Shares") at a 15% discount to the market price of Tern Shares on AIM at market close on the date of the conversion event.  

 

If a conversion event has not occurred by the Maturity Date, then the CLN Holder has the option to elect to convert all of the CLN into Tern Shares at a 15% discount to the five-day average closing price of Tern Shares on AIM immediately prior to the Maturity Date, or, failing such election, the maturity date of the CLN is to be extended for one further year ("the Second Maturity Date"). If a Conversion Event has not taken place by the Second Maturity Date, the CLN will automatically convert into fully paid Tern Shares at a 15% discount to the five-day average closing price of Tern Shares on AIM immediately prior to the Second Maturity Date.

 

Under the terms of the CLN, the CLN Holder has to enter into an orderly market deed ("the Orderly Market Deed") before any issue of Tern Shares can be effected. Under the Orderly Market Deed, the CLN Holder would undertake (subject to customary carve-outs from such restrictions):

 

not to dispose of any interests in such Tern Shares issued and allotted following a Conversion Event for a period of one month following such Conversion Event; not to dispose of any interests in 50% of all such Tern Shares issued and allotted following a Conversion Event for a period of three-months following such Conversion Event; following expiry of the period referred to in paragraph (b), up to the date that is six months following such Conversion Event, not to dispose of any interests in any remaining Tern Shares issued and allotted following such Conversion Event, other than through Tern's nominated adviser (or any nominated adviser or broker appointed to act for Tern in place of the nominated adviser) subject to the terms relating to the price and execution offered by the nominated adviser being materially no less favourable than other brokers at that time; and to use all reasonable endeavours to ensure that its associates comply with the restrictions contained in such undertaking.

The CLN is not transferable other than with the prior consent of Wyld and Tern and is subject to customary terms and conditions for such an instrument.

Enquiries

Tern Plc

Al Sisto/Sarah Payne

via Newgate Communications

 

Allenby Capital

(Nomad and joint broker)

David Worlidge/Alex Brearley

 

Tel: 020 3328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

Tel: 020 7659 1234

 

Newgate Communications

Elisabeth Cowell/Megan Kovach

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCU
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:62205
EQS News ID:1038099
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.